Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 1, 2023
Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: quality of life analysis of TORG 0503Ayako Matsuda, Kazue Yamaoka, Hideo Kunitoh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2003
Identification of D19S246 as a novel lung adenocarcinoma susceptibility locus by genome survey with 10-cM resolution microsatellite markersNoriko Yanagitani, Takashi Kohno, Jeong-Gyoon Kim, et al.
Japanese Journal of Clinical Oncology|October 27, 2022
Observational study to predict the efficacy and optimal duration of nivolumab treatment in patients with previously treated advanced or recurrent non-small cell lung cancerYasushi Goto, Kiyotaka Yoh, Terufumi Kato, et al.
Japanese Journal of Clinical Oncology|December 14, 2024
Outcome of osimertinib-treated patients with epidermal growth factor receptor mutation-positive nonsmall cell lung cancer requiring dose reduction: a secondary analysis of the Reiwa studyNobuyasu Awano, Kiyotaka Yoh, Kazuhiro Usui, et al.
Japanese Journal of Clinical Oncology|August 12, 2006
Pharmacokinetics and pharmacodynamics of weekly epoetin beta in lung cancer patientsYasuhito Fujisaka, Tomohide Tamura, Yuichiro Ohe, et al.
Cancer Science|November 13, 2003
Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patientsHirokazu Watanabe, Seiichiro Yamamoto, Hideo Kunitoh, et al.
Japanese Journal of Clinical Oncology|September 23, 2009
A phase II study of cisplatin and irinotecan as induction chemotherapy followed by accelerated hyperfractionated thoracic radiotherapy with daily low-dose carboplatin in unresectable stage III non-small cell lung cancer: JCOG 9510Tomoki Fujii, Hiroshi Kunikane, Hiroaki Okamoto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2006
Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patientsIkuo Sekine, Minako Sumi, Yoshinori Ito, et al.
Japanese Journal of Clinical Oncology|April 12, 2007
Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or olderToshio Shimizu, Ikuo Sekine, Minako Sumi, et al.
Japanese Journal of Clinical Oncology|March 23, 2024
Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older ('MONEY' trial)Yoko Tsukita, Masataka Taguri, Yasushi Goto, et al.
Pageof 16